Clinical study of the treatment of advanced non small cell lung cancer in elderly over 70 years by gemcitabine
- VernacularTitle:盐酸吉西他滨治疗70岁以上晚期非小细胞肺癌患者的临床观察
- Author:
Liushu LI
;
Ruliang WANG
;
Hui ZHAO
;
Jianhua ZHU
;
Nan DU
- Publication Type:Journal Article
- Keywords:
Carcinoma, non-small-cell lung;
Antincoplastic agents
- From:
Chinese Journal of Geriatrics
2001;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy, toxicity and clinical benefit response of gemcitabine on advanced non small cell lung cancer in elderly. Methods Patients in the chemotherapy arm of the study received gemcitabine 1 250 mg/ m 2 as a intravenous infusion every 21 days .Patients in the best supportive care(BSC) arm should not receive chemotherapy or anticancer therapy. Results Overall survival period in the gemcitabine arm was significantly longer than in the BSC arm ( P
